The 4,000 dead nobody marched for: Ebola and the geography of whose lives count

Four thousand and eighteen. Say the number slowly. It is the official count of the dead in the Democratic Republic of Congo's Ebola outbreak — the worst in the country's history, the second-worst ever recorded anywhere. If 4,018 people had died of anything in a European capital, the world's newsrooms would not sleep. In Congo, they barely woke up. The asymmetry is not an accident. It is a design. The virus killing Congolese today is the Bundibugyo species of Ebola, and there is no licensed vaccine for it — not because science cannot make one, but because science was never asked to. The licensed Ervebo vaccine protects against Zaire Ebola; whether it protects against Bundibugyo, the WHO says, there is 'insufficient evidence' to conclude. Translation: nobody funded the trials, because the people dying were never a market worth the investment. Contrast this with the winter of 2020, when a virus reached the rich world and the mRNA platforms went from sequence to syringe in eleven months, backed by billions in public money and advance purchase agreements. The lesson the pharmaceutical order drew was not that humanity can move fast — it was that humanity moves fast for customers. Congo's dying are not customers. They are, in the cold arithmetic of the industry, an externality. The WHO now rates the national risk 'very high' and warns of cross-border spread; thousands fled an Ebola-hit camp this weekend, which is what people do when the institutions meant to protect them cannot. More than 2,000 have recovered. An experimental drug, obeldesivir, is in trials as post-exposure prophylaxis. These are the scraps of a system that arrives with mobile laboratories after the dying has begun, instead of vaccines before it starts. Periyar taught that rationalism is not the worship of science but the interrogation of whom it serves. Apply that test here and the answer is plain: medical science, as currently organised, serves those who can pay for it. The rest receive charity, trials, and condolences. None of this absolves the Congolese state's own failures — insecurity, broken basic services, and population displacement are, by WHO's own account, driving transmission. But a state hollowed out by a century of extraction cannot be the whole explanation when the extraction continues in the form of neglected research. 4,018 dead. No vaccine. No marches, no minutes of silence, no emergency summits. The geography of grief has borders, and Congo is on the wrong side of every one of them. Until the world treats an African life as worth a vaccine, the dying will be counted meticulously — and the neglect that made it possible will not be counted at all.